American Century Companies’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $718M | Sell |
3,299,346
-196,571
| -6% | -$43.6M | 0.37% | 24 |
|
|
2025
Q4 | $799M | Buy |
3,495,917
+179,126
| +5% | +$40.8M | 0.4% | 21 |
|
|
2025
Q3 | $768M | Sell |
3,316,791
-112,023
| -3% | -$22.8M | 0.39% | 20 |
|
|
2025
Q2 | $636M | Buy |
3,428,814
+349,973
| +11% | +$65M | 0.35% | 28 |
|
|
2025
Q1 | $645M | Sell |
3,078,841
-146,058
| -5% | -$28.4M | 0.4% | 28 |
|
|
2024
Q4 | $573M | Sell |
3,224,899
-121,794
| -4% | -$22.4M | 0.33% | 33 |
|
|
2024
Q3 | $661M | Buy |
3,346,693
+449,044
| +15% | +$83.8M | 0.38% | 31 |
|
|
2024
Q2 | $497M | Buy |
2,897,649
+235,348
| +9% | +$39M | 0.3% | 43 |
|
|
2024
Q1 | $485M | Buy |
2,662,301
+87,521
| +3% | +$15.1M | 0.3% | 47 |
|
|
2023
Q4 | $399M | Buy |
2,574,780
+78,285
| +3% | +$11.4M | 0.27% | 58 |
|
|
2023
Q3 | $372M | Sell |
2,496,495
-150,099
| -6% | -$22M | 0.29% | 59 |
|
|
2023
Q2 | $357M | Sell |
2,646,594
-133,213
| -5% | -$19.5M | 0.27% | 65 |
|
|
2023
Q1 | $442M | Sell |
2,779,807
-105,561
| -4% | -$16.1M | 0.35% | 51 |
|
|
2022
Q4 | $466M | Sell |
2,885,368
-118,235
| -4% | -$18.1M | 0.38% | 49 |
|
|
2022
Q3 | $403M | Buy |
3,003,603
+94,515
| +3% | +$13.6M | 0.35% | 50 |
|
|
2022
Q2 | $446M | Buy |
2,909,088
+1,822,685
| +168% | +$279M | 0.36% | 53 |
|
|
2022
Q1 | $176M | Sell |
1,086,403
-368,824
| -25% | -$53.6M | 0.12% | 195 |
|
|
2021
Q4 | $197M | Buy |
1,455,227
+431,652
| +42% | +$51M | 0.13% | 184 |
|
|
2021
Q3 | $110M | Sell |
1,023,575
-461,798
| -31% | -$52.8M | 0.08% | 273 |
|
|
2021
Q2 | $167M | Buy |
1,485,373
+141,876
| +11% | +$16M | 0.11% | 190 |
|
|
2021
Q1 | $145M | Buy |
1,343,497
+268,906
| +25% | +$28.8M | 0.11% | 221 |
|
|
2020
Q4 | $115M | Buy |
1,074,591
+64,999
| +6% | +$6.25M | 0.09% | 247 |
|
|
2020
Q3 | $88.4M | Buy |
1,009,592
+176,816
| +21% | +$16.6M | 0.08% | 272 |
|
|
2020
Q2 | $81.8M | Sell |
832,776
-592,171
| -42% | -$52.1M | 0.08% | 261 |
|
|
2020
Q1 | $109M | Buy |
1,424,947
+644,483
| +83% | +$54.9M | 0.13% | 202 |
|
|
2019
Q4 | $69.1M | Sell |
780,464
-252,857
| -24% | -$21M | 0.07% | 295 |
|
|
2019
Q3 | $78.2M | Sell |
1,033,321
-236,701
| -19% | -$16.2M | 0.08% | 281 |
|
|
2019
Q2 | $92.4M | Sell |
1,270,022
-324,579
| -20% | -$25.5M | 0.09% | 263 |
|
|
2019
Q1 | $129M | Sell |
1,594,601
-188,840
| -11% | -$15.4M | 0.13% | 212 |
|
|
2018
Q4 | $164M | Buy |
1,783,441
+130,043
| +8% | +$11.4M | 0.19% | 155 |
|
|
2018
Q3 | $156M | Sell |
1,653,398
-93,674
| -5% | -$8.88M | 0.15% | 190 |
|
|
2018
Q2 | $162M | Sell |
1,747,072
-110,145
| -6% | -$10.8M | 0.16% | 178 |
|
|
2018
Q1 | $176M | Sell |
1,857,217
-133,884
| -7% | -$14.7M | 0.18% | 173 |
|
|
2017
Q4 | $193M | Sell |
1,991,101
-158,188
| -7% | -$14.9M | 0.19% | 161 |
|
|
2017
Q3 | $191M | Sell |
2,149,289
-239,877
| -10% | -$18.3M | 0.19% | 163 |
|
|
2017
Q2 | $173M | Sell |
2,389,166
-398,728
| -14% | -$26.8M | 0.18% | 175 |
|
|
2017
Q1 | $182M | Sell |
2,787,894
-352,690
| -11% | -$22.2M | 0.19% | 160 |
|
|
2016
Q4 | $197M | Buy |
3,140,584
+53,228
| +2% | +$3.25M | 0.21% | 141 |
|
|
2016
Q3 | $195M | Sell |
3,087,356
-155,984
| -5% | -$10.1M | 0.21% | 134 |
|
|
2016
Q2 | $201M | Sell |
3,243,340
-208,760
| -6% | -$12.7M | 0.23% | 128 |
|
|
2016
Q1 | $197M | Buy |
3,452,100
+500,219
| +17% | +$27.9M | 0.23% | 126 |
|
|
2015
Q4 | $175M | Buy |
2,951,881
+22,614
| +0.8% | +$1.3M | 0.2% | 138 |
|
|
2015
Q3 | $159M | Buy |
2,929,267
+95,648
| +3% | +$6.23M | 0.19% | 151 |
|
|
2015
Q2 | $190M | Sell |
2,833,619
-1,855,149
| -40% | -$121M | 0.21% | 134 |
|
|
2015
Q1 | $274M | Buy |
4,688,768
+2,406,772
| +105% | +$145M | 0.31% | 89 |
|
|
2014
Q4 | $149M | Buy |
2,281,996
+22,728
| +1% | +$1.43M | 0.17% | 174 |
|
|
2014
Q3 | $130M | Buy |
2,259,268
+11,018
| +0.5% | +$612K | 0.15% | 196 |
|
|
2014
Q2 | $127M | Buy |
2,248,250
+103,320
| +5% | +$5.42M | 0.14% | 192 |
|
|
2014
Q1 | $110M | Sell |
2,144,930
-2,983,252
| -58% | -$151M | 0.13% | 219 |
|
|
2013
Q4 | $271M | Sell |
5,128,182
-252,024
| -5% | -$12.4M | 0.32% | 80 |
|
|
2013
Q3 | $241M | Sell |
5,380,206
-739,678
| -12% | -$32.8M | 0.3% | 87 |
|
|
2013
Q2 | $253M | Buy |
+6,119,884
| New | +$268M | 0.33% | 75 |
|
Other funds holding ABBV
VCM
VPM
American Century Companies's ABBV Position: Q1 2026 in Review
American Century Companies reduced its AbbVie (ABBV) stake by 5.6% in Q1 2026, selling an estimated $43.6M and leaving 3,299,346 shares worth $718M. The position accounts for 0.37% of the portfolio, ranked #24.
American Century Companies first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $799M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- American Century Companies held 3,299,346 shares of AbbVie worth $718M as of Q1 2026.
- American Century Companies sold 196,571 AbbVie shares in Q1 2026, an estimated $43.6M.
- AbbVie made up 0.37% of American Century Companies's portfolio in Q1 2026, its #24 holding.
- American Century Companies first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- American Century Companies's AbbVie position peaked at $799M in Q4 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.